Company Filing History:
4 out of 15 
2 out of 3,385 
1 out of 7 Years Active: 1990-2006
Title: The Innovative Work of John R Riordan in Genetic Research
Introduction:
John R Riordan, a renowned inventor in the field of genetic research, has made significant contributions to the development of diagnostic and therapeutic solutions for cystic fibrosis. With a location in Toronto, CA, Riordan has secured 7 patents, focusing on the cystic fibrosis gene and its applications.
Latest Patents:
Riordan's latest patents involve the detailed description of the cystic fibrosis gene and its gene product, encompassing both normal and mutant forms. These patents have paved the way for advancements in DNA diagnosis, protein diagnosis, carrier and patient screening, drug and gene therapy, gene cloning, protein manufacturing, and the creation of cystic fibrosis affected animal models.
Career Highlights:
Throughout his career, John R Riordan has been associated with notable institutions such as the Hsc Research Development Corporation, where he has dedicated his expertise to groundbreaking research in the field of genetics. His innovative approach and commitment to advancing medical science have earned him recognition as a pioneer in genetic studies.
Collaborations:
Riordan has collaborated with esteemed colleagues in his endeavors, including Francis S Collins and Johanna M Rommens. Together, they have synergized their skills and knowledge to drive forward the development of novel genetic technologies and therapies for cystic fibrosis and other genetic disorders.
Conclusion:
In conclusion, John R Riordan's inventive work in genetic research has significantly influenced the landscape of medical science, particularly in the realm of cystic fibrosis diagnostics and treatments. His patents and collaborations stand as a testament to his dedication to innovation and his enduring impact on the field of genetics.